journal article·2006-09-05

Heparinized Magnetic Nanoparticles: In‐Vitro Assessment for Biomedical Applications

S. C. Wuang, K. G. Neoh, E.‐T. Kang, D. W. Pack, D. E. Leckband

Advanced Functional Materials· Volume 16· Issue 13
Publisher page

Abstract

Abstract Superparamagnetic magnetite nanoparticles are of great interest owing to their numerous existing and potential biomedical applications. In this study, superparamagnetic magnetite nanoparticles with average diameters of 6–8 nm have been prepared and surface‐functionalized with poly(N‐isopropylacrylamide) (poly(NIPAAM)) via a surface‐initiated atom‐transfer radical polymerization, followed by immobilization of heparin. The success of the various surface‐functionalization steps has been ascertained using Fourier transform infrared spectroscopy and X‐ray photoelectron spectroscopy. The rate of internalization of the as‐synthesized and surface‐functionalized magnetite nanoparticles by mouse macrophage cells has been investigated. The nanoparticle internalization into the macrophages has been visualized using optical microscopy and quantified by inductively coupled plasma spectroscopy. The effectiveness of the heparinized nanoparticles in preventing thrombosis has been determined using the plasma recalcification time. The results indicate that the above‐mentioned surface modifications of the magnetite nanoparticles are effective in delaying phagocytosis and preventing blood clotting in vitro. Such properties can be expected to enable their use in biomedical applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Blood properties and coagulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. 10.1088/0022-3727/36/13/20110.1088/0022-3727/36/13/201 ↗
2. 10.1088/0022-3727/36/13/20210.1088/0022-3727/36/13/202 ↗
3. Berry C. C. · J. Phys. D · 2003 · 36 · R19810.1088/0022-3727/36/13/203 ↗
4. 10.1084/jem.150.5.120210.1084/jem.150.5.1202 ↗
5. 10.1023/A:101193012756210.1023/A:1011930127562 ↗
6. 10.1002/anie.20030170810.1002/anie.200301708 ↗
7. Hammerle H. · Vasa · 1991 · 20 · 207
8. 10.1016/S0008-6363(98)00049-210.1016/S0008-6363(98)00049-2 ↗
9. 10.1002/app.1161210.1002/app.11612 ↗
10. 10.1016/j.radphyschem.2004.09.02810.1016/j.radphyschem.2004.09.028 ↗
11. 10.1002/pola.2008510.1002/pola.20085 ↗
12. 10.1016/S0927-7757(98)00745-610.1016/S0927-7757(98)00745-6 ↗
13. 10.1016/S0005-2736(99)00117-010.1016/S0005-2736(99)00117-0 ↗
14. 10.1016/j.biomaterials.2005.05.09410.1016/j.biomaterials.2005.05.094 ↗
15. J. F. Moulder W. F. Stickle P. E. Sobol K. D. Bomben inHandbook of X‐ray Photoelectron Spectroscopy(Ed: J. Chastain) Perkin‐Elmer Eden Prairie MN1992 Ch. 2.
16. G. Beamson D. Briggs High Resolution XPS of Organic Polymers: The Scienta ESCA Database Wiley Chichester UK1992.
17. R. M. Silverstein F. X. Webster Spectrometric Identification of Organic compounds 6th ed. Wiley New York1997 Ch. 3.
18. 10.1039/b402025a10.1039/b402025a ↗
19. 10.1021/cm960077f10.1021/cm960077f ↗
20. 10.1109/20.95112210.1109/20.951122 ↗
21. 10.1039/b315103d10.1039/b315103d ↗
22. 10.1021/ja031776d10.1021/ja031776d ↗
23. 10.1021/ja038059410.1021/ja0380594 ↗
24. 10.1016/S0304-8853(00)01238-510.1016/S0304-8853(00)01238-5 ↗
25. Maaßen S. · STP Pharm. Sci. · 1993 · 3 · 11
26. 10.1146/annurev.mi.32.100178.00031510.1146/annurev.mi.32.100178.000315 ↗
27. 10.1016/0142-9612(88)90033-610.1016/0142-9612(88)90033-6 ↗
28. 10.3109/1061186000899686210.3109/10611860008996862 ↗
29. 10.1016/S0024-3205(97)01175-210.1016/S0024-3205(97)01175-2 ↗
30. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
31. J. F.Drake J.Franklin US Patent 6 060 461 1999.
32. 10.1021/ja038085210.1021/ja0380852 ↗
33. 10.1016/j.polymer.2004.02.00510.1016/j.polymer.2004.02.005 ↗
34. 10.1016/j.polymer.2004.10.07710.1016/j.polymer.2004.10.077 ↗
35. 10.1002/jbm.82020080810.1002/jbm.820200808 ↗